Globally, Synokem is growing its reach in the different markets of the world. We are in constant search of partners that match our values, work ethics and commitment to patients. We regard partnership and collaboration as an integral part of our business strategy. Our Regulatory expertise, backed by sophisticated manufacturing capabilities, enables us to offer Formulations in global markets. We will, therefore, continue to nurture new and existing partners, who can complement our capabilities in foreign markets. This important initiative is supported by a dedicated team for global business development.
Synokem Pharmaceuticals Limited began spreading its wings beyond India with thrust on becoming a global player in the international market. Synokem is one of the few Indian Pharma enterprises to make a foray into exports successfully.
The focus of Synokem is on innovating the future through the development of new health products and to make them available at all pharmacies worldwide. In every single action; the guiding values of Integrity, Quality, Excellence, Unity, Results and Teamwork.
Synokem moved step ahead and ventured into Exports. In the year 2012, started from SAARC countries and got approved in SRILANKA (CDDA). Synokem covered the neighbouring countries in 2013, got approved with MOH CAMBODIA and MYANMAR. Having 5 Registration in each country. Presently we have 25 products in each country under registration in SOUTHEAST ASIA.
More to come Synokem will be soon PICS approved as well. Proud for Synokem come with the entry in AFRICA, from KENYA. We got inspected by PPB in year 2016 march and received KENYA GMP Certificate in may 2016.
Where as next countries those will be markets for Synokem are:
In AFRICA Uganda, Tanzania, Zambia, Cameron, Ivory Coast, Senegal, Nigeria, Botswana and Kenya
In SAARC Nepal, Bhutan And Sri Lanka
In CIS Tajikistan, Kazakhstan, Uzbekistan And Serbia
In LATAM Ecuador, Peru And Bolivia